Literature DB >> 11170896

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.

A Richards1, M R Buddles, R L Donne, B S Kaplan, E Kirk, M C Venning, C L Tielemans, J A Goodship, T H Goodship.   

Abstract

Several recent studies have established an association between abnormalities of complement factor H (FH) and the development of hemolytic uremic syndrome (HUS). To identify the relative importance of mutations in FH as a cause of HUS, we have undertaken mutation screening of the FH gene in 19 familial and 31 sporadic patients with FH. Mutations were found in two familial and three sporadic patients, and these clustered in exons 18-20, a domain important for host recognition. Moreover, this study demonstrates that familial HUS is likely to be a heterogeneous condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170896      PMCID: PMC1235281          DOI: 10.1086/318203

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism.

Authors:  B H Ault; B Z Schmidt; N L Fowler; C E Kashtan; A E Ahmed; B A Vogt; H R Colten
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

2.  Genetic studies into inherited and sporadic hemolytic uremic syndrome.

Authors:  P Warwicker; T H Goodship; R L Donne; Y Pirson; A Nicholls; R M Ward; P Turnpenny; J A Goodship
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

3.  The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins.

Authors:  W M Prodinger; J Hellwage; M Spruth; M P Dierich; P F Zipfel
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

4.  Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H.

Authors:  T K Blackmore; T A Sadlon; H M Ward; D M Lublin; D L Gordon
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

5.  Bi-directional dideoxy fingerprinting (Bi-ddF): a rapid method for quantitative detection of mutations in genomic regions of 300-600 bp.

Authors:  Q Liu; J Feng; S S Sommer
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

6.  Disruption of disulfide bonds is responsible for impaired secretion in human complement factor H deficiency.

Authors:  B Z Schmidt; N L Fowler; T Hidvegi; D H Perlmutter; H R Colten
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 7.  The factor H protein family.

Authors:  P F Zipfel; T S Jokiranta; J Hellwage; V Koistinen; S Meri
Journal:  Immunopharmacology       Date:  1999-05

8.  Identification of the second heparin-binding domain in human complement factor H.

Authors:  T K Blackmore; J Hellwage; T A Sadlon; N Higgs; P F Zipfel; H M Ward; D L Gordon
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

9.  Heterozygous and homozygous factor H deficiency states in a Dutch family.

Authors:  C A Fijen; E J Kuijper; M Te Bulte; M M van de Heuvel; A C Holdrinet; R B Sim; M R Daha; J Dankert
Journal:  Clin Exp Immunol       Date:  1996-09       Impact factor: 4.330

10.  Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura.

Authors:  M Noris; P Ruggenenti; A Perna; S Orisio; J Caprioli; C Skerka; B Vasile; P F Zipfel; G Remuzzi
Journal:  J Am Soc Nephrol       Date:  1999-02       Impact factor: 10.121

View more
  111 in total

1.  The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion.

Authors:  Guido A Hegasy; Tamara Manuelian; Kolbjorn Hogasen; Johan H Jansen; Peter F Zipfel
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

3.  Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis.

Authors:  Paula Bertram; Antonina M Akk; Hui-fang Zhou; Lynne M Mitchell; Christine T N Pham; Dennis E Hourcade
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-02

4.  The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.

Authors:  M Oppermann; T Manuelian; M Józsi; E Brandt; T S Jokiranta; S Heinen; S Meri; C Skerka; O Götze; P F Zipfel
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

5.  Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

Authors:  Jessica Caprioli; Marina Noris; Simona Brioschi; Gaia Pianetti; Federica Castelletti; Paola Bettinaglio; Caterina Mele; Elena Bresin; Linda Cassis; Sara Gamba; Francesca Porrati; Sara Bucchioni; Giuseppe Monteferrante; Celia J Fang; M K Liszewski; David Kavanagh; John P Atkinson; Giuseppe Remuzzi
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

6.  The C-terminus of complement factor H is essential for host cell protection.

Authors:  Mihály Józsi; Martin Oppermann; John D Lambris; Peter F Zipfel
Journal:  Mol Immunol       Date:  2007-01-17       Impact factor: 4.407

7.  Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia.

Authors:  Yoshiyasu Ueda; Takashi Miwa; Damodar Gullipalli; Sayaka Sato; Daisuke Ito; Hangsoo Kim; Matthew Palmer; Wen-Chao Song
Journal:  J Am Soc Nephrol       Date:  2018-06-01       Impact factor: 10.121

8.  Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population.

Authors:  R Martínez-Barricarte; E Goicoechea de Jorge; T Montes; A G Layana; S Rodríguez de Córdoba
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality.

Authors:  Angela Gerber; Antje H Kirchhoff-Moradpour; Silke Obieglo; Matthias Brandis; Michael Kirschfink; Peter F Zipfel; Judith A Goodship; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

10.  Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.

Authors:  Johannes Hofer; Andreas R Janecke; L B Zimmerhackl; Magdalena Riedl; Alejandra Rosales; Thomas Giner; Gerard Cortina; Carola J Haindl; Barbara Petzelberger; Miriam Pawlik; Verena Jeller; Udo Vester; Bettina Gadner; Michael van Husen; Michael L Moritz; Reinhard Würzner; Therese Jungraithmayr
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.